SANOFI-ADR (SNY) Stock Fundamental Analysis
USA - NASDAQ:SNY - US80105N1054 - ADR
50.26 USD
-0.32 (-0.63%)
Overall SNY gets a fundamental rating of 6 out of 10. We evaluated SNY against 192 industry peers in the Pharmaceuticals industry. SNY scores excellent on profitability, but there are some minor concerns on its financial health. SNY may be a bit undervalued, certainly considering the very reasonable score on growth Finally SNY also has an excellent dividend rating.
1. Profitability
1.1 Basic Checks
SNY had positive earnings in the past year.
SNY had a positive operating cash flow in the past year.
Each year in the past 5 years SNY has been profitable.
SNY had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 11.05%, SNY belongs to the top of the industry, outperforming 93.23% of the companies in the same industry.
With an excellent Return On Equity value of 19.73%, SNY belongs to the best of the industry, outperforming 92.19% of the companies in the same industry.
SNY has a Return On Invested Capital of 13.84%. This is amongst the best in the industry. SNY outperforms 92.19% of its industry peers.
SNY had an Average Return On Invested Capital over the past 3 years of 7.31%. This is significantly below the industry average of 15.40%.
The 3 year average ROIC (7.31%) for SNY is below the current ROIC(13.84%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.05% | ||
| ROE | 19.73% | ||
| ROIC | 13.84% |
ROA(3y)5.02%
ROA(5y)6.2%
ROE(3y)8.55%
ROE(5y)10.84%
ROIC(3y)7.31%
ROIC(5y)7.07%
1.3 Margins
The Profit Margin of SNY (20.35%) is better than 93.75% of its industry peers.
In the last couple of years the Profit Margin of SNY has grown nicely.
Looking at the Operating Margin, with a value of 23.59%, SNY belongs to the top of the industry, outperforming 90.10% of the companies in the same industry.
In the last couple of years the Operating Margin of SNY has grown nicely.
With a decent Gross Margin value of 71.70%, SNY is doing good in the industry, outperforming 79.17% of the companies in the same industry.
SNY's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 23.59% | ||
| PM (TTM) | 20.35% | ||
| GM | 71.7% |
OM growth 3Y-2.73%
OM growth 5Y1.75%
PM growth 3Y-7.54%
PM growth 5Y11.4%
GM growth 3Y0.71%
GM growth 5Y0.58%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), SNY is creating value.
Compared to 1 year ago, SNY has about the same amount of shares outstanding.
SNY has about the same amout of shares outstanding than it did 5 years ago.
Compared to 1 year ago, SNY has an improved debt to assets ratio.
2.2 Solvency
SNY has a debt to FCF ratio of 2.21. This is a good value and a sign of high solvency as SNY would need 2.21 years to pay back of all of its debts.
The Debt to FCF ratio of SNY (2.21) is better than 92.71% of its industry peers.
SNY has a Debt/Equity ratio of 0.21. This is a healthy value indicating a solid balance between debt and equity.
SNY's Debt to Equity ratio of 0.21 is in line compared to the rest of the industry. SNY outperforms 44.79% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | 2.21 | ||
| Altman-Z | N/A |
ROIC/WACC1.86
WACC7.45%
2.3 Liquidity
A Current Ratio of 1.27 indicates that SNY should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.27, SNY is doing worse than 75.00% of the companies in the same industry.
A Quick Ratio of 0.94 indicates that SNY may have some problems paying its short term obligations.
SNY's Quick ratio of 0.94 is on the low side compared to the rest of the industry. SNY is outperformed by 75.52% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.27 | ||
| Quick Ratio | 0.94 |
3. Growth
3.1 Past
SNY shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -5.35%.
SNY shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 5.10% yearly.
The Revenue has been growing slightly by 2.56% in the past year.
The Revenue has been growing slightly by 3.31% on average over the past years.
EPS 1Y (TTM)-5.35%
EPS 3Y5.45%
EPS 5Y5.1%
EPS Q2Q%1.75%
Revenue 1Y (TTM)2.56%
Revenue growth 3Y4.17%
Revenue growth 5Y3.31%
Sales Q2Q%-7.47%
3.2 Future
SNY is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.84% yearly.
SNY is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.46% yearly.
EPS Next Y4.12%
EPS Next 2Y6.3%
EPS Next 3Y6.57%
EPS Next 5Y6.84%
Revenue Next Year-0.42%
Revenue Next 2Y3.06%
Revenue Next 3Y4.26%
Revenue Next 5Y4.46%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 11.45, which indicates a very decent valuation of SNY.
Compared to the rest of the industry, the Price/Earnings ratio of SNY indicates a rather cheap valuation: SNY is cheaper than 89.58% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.11, SNY is valued rather cheaply.
A Price/Forward Earnings ratio of 10.03 indicates a reasonable valuation of SNY.
85.42% of the companies in the same industry are more expensive than SNY, based on the Price/Forward Earnings ratio.
SNY's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.55.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.45 | ||
| Fwd PE | 10.03 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SNY indicates a rather cheap valuation: SNY is cheaper than 96.88% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of SNY indicates a rather cheap valuation: SNY is cheaper than 91.15% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 10.53 | ||
| EV/EBITDA | 5.8 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates SNY does not grow enough to justify the current Price/Earnings ratio.
SNY has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)2.78
PEG (5Y)2.25
EPS Next 2Y6.3%
EPS Next 3Y6.57%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 4.45%, SNY is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 6.54, SNY pays a better dividend. On top of this SNY pays more dividend than 96.35% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.37, SNY pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.45% |
5.2 History
The dividend of SNY has a limited annual growth rate of 4.30%.
SNY has been paying a dividend for at least 10 years, so it has a reliable track record.
The dividend of SNY decreased in the last 3 years.
Dividend Growth(5Y)4.3%
Div Incr Years2
Div Non Decr Years2
5.3 Sustainability
SNY pays out 34.82% of its income as dividend. This is a sustainable payout ratio.
SNY's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP34.82%
EPS Next 2Y6.3%
EPS Next 3Y6.57%
NASDAQ:SNY (11/3/2025, 12:59:04 PM)
50.26
-0.32 (-0.63%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners47.5%
Inst Owner Change-1.42%
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap122.49B
Revenue(TTM)66.91B
Net Income(TTM)13.81B
Analysts81.38
Price Target62.28 (23.92%)
Short Float %0.22%
Short Ratio1.47
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.45% |
Yearly Dividend2.19
Dividend Growth(5Y)4.3%
DP34.82%
Div Incr Years2
Div Non Decr Years2
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.86%
Min EPS beat(2)-2.29%
Max EPS beat(2)6.02%
EPS beat(4)2
Avg EPS beat(4)4.01%
Min EPS beat(4)-2.29%
Max EPS beat(4)14.5%
EPS beat(8)4
Avg EPS beat(8)2.17%
EPS beat(12)7
Avg EPS beat(12)2.71%
EPS beat(16)11
Avg EPS beat(16)3.44%
Revenue beat(2)0
Avg Revenue beat(2)-0.96%
Min Revenue beat(2)-1.3%
Max Revenue beat(2)-0.63%
Revenue beat(4)1
Avg Revenue beat(4)-0.71%
Min Revenue beat(4)-4.57%
Max Revenue beat(4)3.66%
Revenue beat(8)2
Avg Revenue beat(8)-1.12%
Revenue beat(12)4
Avg Revenue beat(12)9.26%
Revenue beat(16)8
Avg Revenue beat(16)21.08%
PT rev (1m)-3.89%
PT rev (3m)-4.25%
EPS NQ rev (1m)-4.58%
EPS NQ rev (3m)-8.85%
EPS NY rev (1m)-0.66%
EPS NY rev (3m)-4.48%
Revenue NQ rev (1m)-1.49%
Revenue NQ rev (3m)-2.89%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.41%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.45 | ||
| Fwd PE | 10.03 | ||
| P/S | 1.56 | ||
| P/FCF | 10.53 | ||
| P/OCF | 9.32 | ||
| P/B | 1.51 | ||
| P/tB | 11.41 | ||
| EV/EBITDA | 5.8 |
EPS(TTM)4.39
EY8.73%
EPS(NY)5.01
Fwd EY9.97%
FCF(TTM)4.77
FCFY9.5%
OCF(TTM)5.4
OCFY10.73%
SpS32.19
BVpS33.19
TBVpS4.41
PEG (NY)2.78
PEG (5Y)2.25
Graham Number57.26
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.05% | ||
| ROE | 19.73% | ||
| ROCE | 16.7% | ||
| ROIC | 13.84% | ||
| ROICexc | 16.48% | ||
| ROICexgc | 66.95% | ||
| OM | 23.59% | ||
| PM (TTM) | 20.35% | ||
| GM | 71.7% | ||
| FCFM | 14.83% |
ROA(3y)5.02%
ROA(5y)6.2%
ROE(3y)8.55%
ROE(5y)10.84%
ROIC(3y)7.31%
ROIC(5y)7.07%
ROICexc(3y)8.13%
ROICexc(5y)7.97%
ROICexgc(3y)35.39%
ROICexgc(5y)35.54%
ROCE(3y)8.84%
ROCE(5y)8.55%
ROICexgc growth 3Y-13.63%
ROICexgc growth 5Y-1.43%
ROICexc growth 3Y-1.55%
ROICexc growth 5Y2.05%
OM growth 3Y-2.73%
OM growth 5Y1.75%
PM growth 3Y-7.54%
PM growth 5Y11.4%
GM growth 3Y0.71%
GM growth 5Y0.58%
F-Score7
Asset Turnover0.54
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | 2.21 | ||
| Debt/EBITDA | 0.75 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 58.05% | ||
| Profit Quality | 72.91% | ||
| Current Ratio | 1.27 | ||
| Quick Ratio | 0.94 | ||
| Altman-Z | N/A |
F-Score7
WACC7.45%
ROIC/WACC1.86
Cap/Depr(3y)73.02%
Cap/Depr(5y)67.36%
Cap/Sales(3y)6.35%
Cap/Sales(5y)5.97%
Profit Quality(3y)113.82%
Profit Quality(5y)104.22%
High Growth Momentum
Growth
EPS 1Y (TTM)-5.35%
EPS 3Y5.45%
EPS 5Y5.1%
EPS Q2Q%1.75%
EPS Next Y4.12%
EPS Next 2Y6.3%
EPS Next 3Y6.57%
EPS Next 5Y6.84%
Revenue 1Y (TTM)2.56%
Revenue growth 3Y4.17%
Revenue growth 5Y3.31%
Sales Q2Q%-7.47%
Revenue Next Year-0.42%
Revenue Next 2Y3.06%
Revenue Next 3Y4.26%
Revenue Next 5Y4.46%
EBIT growth 1Y15.64%
EBIT growth 3Y1.33%
EBIT growth 5Y5.12%
EBIT Next Year30.73%
EBIT Next 3Y13.89%
EBIT Next 5Y9.93%
FCF growth 1Y24.23%
FCF growth 3Y-11.46%
FCF growth 5Y-0.14%
OCF growth 1Y10.87%
OCF growth 3Y-4.79%
OCF growth 5Y3.31%
SANOFI-ADR / SNY FAQ
What is the fundamental rating for SNY stock?
ChartMill assigns a fundamental rating of 6 / 10 to SNY.
What is the valuation status for SNY stock?
ChartMill assigns a valuation rating of 8 / 10 to SANOFI-ADR (SNY). This can be considered as Undervalued.
How profitable is SANOFI-ADR (SNY) stock?
SANOFI-ADR (SNY) has a profitability rating of 8 / 10.
What is the valuation of SANOFI-ADR based on its PE and PB ratios?
The Price/Earnings (PE) ratio for SANOFI-ADR (SNY) is 11.45 and the Price/Book (PB) ratio is 1.51.
Can you provide the financial health for SNY stock?
The financial health rating of SANOFI-ADR (SNY) is 4 / 10.